ICP0 is a multifunctional herpes simplex virus protein known primarily as a promiscuous transactivator. In the course of productive infection, it is localized during the first 5-7 h in the nucleus and later in the cytoplasm. In the nucleus, its primary activities are to suppress the silencing of viral DNA by host proteins, activate cdk4 through recruitment of cyclin D3 to the sites of formation of replication compartments, and degrade several cellular proteins including PML and Sp100, key components of the ND10 nuclear bodies. ICP0 is not translocated to the cytoplasm in cells infected with mutants incapable of performing these tasks. We report the unexpected finding that ICP0 is cleaved into several discrete polypeptides by a proteasome-independent process. The products of this cleavage accumulate in cells infected with ICP0 mutants incapable of degrading PML and therefore are retained in the nucleus. In the second step, the products of the initial cleavage of wild-type virus-infected cells are themselves subject to proteasome-dependent degradation. The average half life of intact ICP0 during the nuclear phase is approximately 1 h. The proteasomeindependent cleavage products are no longer detected at late times corresponding to the cytoplasmic phase of ICP0. The results are consistent with the hypothesis that the cleavage products of ICP0 function in topologically distinct domains during its nuclear phase.
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herpes simplex virus ͉ nuclear proteolysis ͉ proteasome dependent I CP0 (infected cell protein No. 0) is a remarkable multifunctional herpes simplex virus (HSV) protein whose primary functions early in infection are to overcome host defenses and set the stage for efficient replication of the virus. The 775-residue protein is the product of three exons of ␣0, a gene expressed immediately after infection (1) . The protein first appears and is localized in nuclear structures known as ND10 or PODs (2, 3) . At least 3 important functions are associated with ICP0 at this stage. Thus (i) ICP0 enhances the localization of cyclin D3 to ND10 bodies that serve as precursors of replication compartments, results in activation of cdk4, and enables efficient viral replication in resting, contact-inhibited cells (4) . (ii) Acting as an ubiquitin ligase, and in conjunction with the ubiquitinconjugating enzyme UbcH5a, ICP0 degrades PML and Sp100, the major constituents of ND10 (5) . One objective in targeting PML is to prevent exogenous IFN from blocking viral replication, a function readily demonstrable in murine cells in which IFN is highly effective in inhibiting the replication of wild-type HSV in wild-type cells but not in PML-/-sibling cells (6) . (iii) ICP0 suppresses the silencing of viral DNA by dissociating either HDAC1 or 2 from the HDAC/CoREST/REST/LSD1 complex localized at the ND10 structures (7, 8) and (iv) causes the dispersal of the ND10 structures (2) . In the next 1 to 2 h, ICP0 fills the nucleus and is then translocated to the cytoplasm (9) . The length of the sojourn in the nucleus is to some extent cell type-dependent. In human embryonic lung (HEL) fibroblasts, the duration of the nuclear phase is approximately 5 h.
In this report we show that ICP0 turns over very rapidly in the course of its nuclear sojourn. The protein is degraded in at least two steps. The first step is unaffected by proteasomal inhibitors and results in accumulation of a multiple polypeptides that form discrete bands in denaturing polyacrylamide gels. The second step results in the total degradation of the products of the initial cleavage in a proteasome-dependent fashion. The results also indicate that the proteasome-independent degradation of ICP0 takes place in the nucleus.
Relevant to this report are the following: ICP0 localizes and is dispersed throughout the cytoplasm late in infection of HEL cells or HEp-2 cells with wild-type virus (9) . In cells infected with virus carrying amino acid substitutions in the RING domain that is incapable of degrading PML, ICP0 is sequestered in the nucleus (10) . In cells infected with a virus mutant carrying amino acid substitutions in the CoREST binding site, ICP0 accumulates in the nucleus of all cells, but in approximately 60% of the cells, ICP0 is also present in the cytoplasm (10) . Similarly, ICP0 is retained in the nucleus of cells infected with a mutant incapable of binding cyclin D3 (11) . ICP0 is also retained in the nucleus of HEL or HEp-2 cells transfected with DNA before infection (12) . The fundamental conclusion of these studies is that ICP0 is retained in the nucleus until its nuclear tasks are executed and that increasing the amount of DNA that aggregates at ND10 bodies augments its tasks.
A possible exception to this rule is the translocation of ICP0 to the cytoplasm in cells infected with a mutant (d120) lacking the gene encoding the major regulatory protein ICP4. In these cells, ICP0 is translocated to the cytoplasm and aggregates in dense bodies with proteasomal components between 3-5 h after infection.
Results

ICP0 Is Degraded Early in Infection with
Wild-Type Virus. We report two series of experiments. In the first, HEL cells were treated with cycloheximide (100 g/mL) at either 3 ( Fig. 1 A, lanes 2-8, and C, lanes 2-7) or 5 h (Fig. 1C, lanes 9-11) after exposure of the cells to 5 PFU wild-type [HSV-1(F)] virus per cell. The cells were harvested at 30 min intervals (Fig. 1 A) or 2 h intervals (Fig.  1C) . At times indicated, MG132 (10 M) was added to the medium. The cells were harvested at times indicated and the proteins were extracted, solubilized, subjected to electrophoresis in denaturing gels, and the ICP0-related bands were visualized by ECL or ECL-plus with antibody directed to the ICP0 domain encoded by exon 2. The bands were scanned with the aid of a Molecular Dynamics Storm Imager and normalized with respect to the host protein that reacts with the anti ICP0 antibody (marked as ''h''; see Figure 1C ). The results of the scanning of the intact ICP0 and the major product of degradation of ICP0 identified as the 66kDa band in Fig. 1 A are shown in Fig. 1B . The results ( Fig. 1 A-C) may be summarized as follows:
(i). The half life of full-length ICP0 at 3 h after infection based on the scan of Fig. 1 A is approximately 1 h (Fig. 1B) . The half life of the major product of ICP0 cleavage (66 kDa) appears to be similar to that of the full-length ICP0 at early times but somewhat slower, between 4.5 and 7 h after infection (Fig. 1B) . Rapid degradation of ICP0 is also apparent from data presented in Fig. 1C, lanes 1-4, 8, and9 .
(ii) All of the products of degradation of ICP0 ranging in size from 37-66 kDa observed initially at 3 h ( Fig. 1 A, (iii) Addition of both cycloheximide and MG132 to the medium at the same time results in the selective conservation of the 66-kDa band. All other cleavage products of ICP0 disappear (Fig. 1C, lanes 5 and 10) . The 66-kDa protein disappears if the addition of MG132 is delayed by 2 h (Fig. 1C, lanes 6 and 11) or 4 h (Fig. 1C, lane 7) .
In the second series of experiments, HEL cells were exposed to HSV-1(F) (5 PFU/cell) alone or in the presence of either lactacystin (5 M) or Z-VAD-FMK (25 M). The cells were harvested at 9 h after infection and processed as described above. The results shown in Fig. 1D indicated that the initial cleavage products that include the 66-kDa protein accumulate in the presence of lactacystin but only traces of these proteins remain in the lysates of untreated infected cells at 9 h after infection (compare Fig. 1D , lanes 2 and 6). Z-VAD-FMK enabled the accumulation of the 66-kDa cleavage product but not of the smaller, fast migrating cleavage products (compare Fig. 1D lanes 2, 4, and 6.).
We conclude that MG132 and Z-VAD-FMK do not block the cleavage of the full-length ICP0 into the 66-kDa polypeptides. Both drugs block further degradation of the 66-kDa protein into smaller cleavage products. Lactacystin does not block the production of the 66-kDa protein or the smaller polypeptides but does block further degradation of these cleavage products. The results indicate that ICP0 is degraded in two steps. The first is by proteasome-independent cleavage that results in the accumulation of at least five discrete bands demonstrable by their interaction with antibody to exon 2 sequences. The second is the degradation of initial cleavage products by a proteasomedependent process. We cannot exclude the possibility that the degradation of the 66-kDa protein involves caspases since it is selectively spared from degradation by the caspase inhibitor.
In control experiments, we showed that the detection of degradation products of ICP0 was independent of the antibody used for their detection (Fig. S1 A) . In that experiment, the antibodies used were monoclonal antibody to ICP0 domain encoded by exon 3, Monoclonal antibody kindly provided by S. Silverstein to ICP0 domain encoded by exon 1, polyclonal antibody to ICP0 domain encoded by exon 2, and finally, to a CMV epitope inserted in front of ICP0 domain encoded by exon 1.
In the second control experiment shown as Fig. S1B , we demonstrated that ICP0 cleavage products were virus strain independent. The strains used in these studies were HSV-1(F), HSV-1 (17), and HSV-1(KOS). The minor differences in the cleavage patterns could be due to difference in amino acid sequences of the three HSV-1 strains (Fig. S2 ). It is of interest to note that all of the differences were in the ICP0 domain encoded by exon 3.
The Apparent Rate of Proteasome-Independent Degradation of ICP0
Decreases with Time after Infection. The results of the experiment shown in Fig. 1B suggested that the rate of degradation of ICP0 decreases with time after infection. To verify this observation, we used the procedures outlines in Fig. 2A . Briefly replicate cultures of HEL cells were exposed to 10 PFU/cell of HSV-1(F). At 1 h after infection, the cells were replenished with methionine-free medium supplemented with [ 35 S] methionine (Perkin-Elmer Life Sciences). After 40 min of incubation, the cells were rinsed and incubated either with growth medium alone or growth medium with MG132 (10 M). The cells were harvested after a 2 h chase, solubilized, and reacted with antibody to ICP0 domain encoded by exon 2. This procedure was repeated at 5 and 9 h after infection. The immune precipitates were harvested, solubilized, and subjected to electrophoresis on denaturing gels. The autoradiographic images were scanned with the aid of a Molecular Dynamics Storm Imager. The results, in Fig. 2 , show the following.
In all samples labeled at 1 and 5 h after infection, the ratio of the 66-kDa protein to full-length ICP0 increases with time. Furthermore, the ratios are higher in the samples trated with 1-4) . The inhibitors were added at the time of exposure of virus to cells. The cells were harvested at 9 h after infection, and the total cell lysates were electropheretically separated and immunoblotted with antibody to ICP0 domain encoded by exon 2.
MG132 during the chase than in untreated samples. In contrast, the ratio of the 66-kDa protein to ICP0 drastically decreases at 9 h after infection and furthermore, there is no appreciable change between the amounts of either the 66-kDa protein or full-length ICP0 in untreated and treated cultures labeled at 9 h after infection. These results indicate that the degradation of newly labeled ICP0 or of its 66-kDa degradation product practically ceases at 9 after infection, at the time when wild-type ICP0 accumulates in the cytoplasm.
The ratios of full-length ICP0 in cultures treated with MG132 during the chase period to those in untreated cultures indicate that highest rate of degradation of ICP0 was in cultures labeled at 1 h after infection. The ratio decreased in cultures labeled at 5 h after infection and was essentially undetectable in cultures labeled at 9 h after infection.
The conclusion to be drawn from this experiment is that ICP0 is degraded most rapidly during the times after infection that coincide with its nuclear localization but appears to remain stable at times that coincide with its cytoplasmic localization.
Accumulation of the Initial Cleavage Products of ICP0 Carrying Mutations in the RING Domain and in the CoREST-Binding Site. We report two series of experiments. In the first (Fig. 3A) , HEL cells were mock-infected or exposed to 5 PFU of HSV-1(F), RING finger mutant (RFm), or CoREST-binding domain mutant (Com) per cells. The cells were harvested and lysed at times indicated. The solubilized proteins were subjected to electrophoresis in denaturing gels and reacted with anti-exon 2 antibody as described above. The arrowhead points to a host protein that serves as a loading control. The letters a and b identify the full-length and 66-kDa cleavage products, respectively. The results (Fig. 3A) show the following:
The amount of full-length ICP0 detected in cells infected with the HSV-1(F) was higher at 9 h than at 5 h. The amounts of degradation products of ICP0 at 9 h were lower or at least not commensurate with the relative quantities of full length ICP0 (compare Fig. 3A lanes 1 and 2) .
In cells infected with RING domain mutant (Fig. 3A, lanes 3  and 4) , the 66-kDa cleavage product accumulated in larger amounts at 9 h compared to 5 h after infection. Since ICP0 produced by the RING domain mutant is sequestered in the nucleus (10), the results suggest that the ICP0 continued to be produced throughout the 9 h interval, that cleavage products accumulated, and that the secondary, proteasome-dependent degradation of the cleavage products was either reduced in amount or did not take place.
In contrast, the amounts of full-length and cleavage products of ICP0 in cell infected with the CoREST-binding site mutant were not significantly different from those in cells infected with wild-type virus. In contrast to the RING domain mutants, ICP0 carrying the RING figure mutant is retained in the nucleus whereas ICP0 produced by the CoREST-binding site mutant accumulates in both nucleus and cytoplasm (10) . Thus, the degradation of the initial cleavage products is either related to the degradation of PML and dispersal of ND10 structures, a feature of both wild-type virus and CoREST-binding site mutants, or degradation of the initial cleavage products is dependent on transport to the cytoplasm.
In the second series of experiments (Fig. 3B) , HEL cells were mock-infected or exposed to 5 PFU of wild-type, RING finger, ⌬ICP0, or ⌬ICP4 mutant virus per cell. The cells were exposed at the time of infection to MG132 (10 M). The cells were harvested at 9 h after infection and processed as above. The results were as follows:
(i). In cells infected with RFm and ⌬ICP4, the accumulation of cleavage products of ICP0 was not affected by the exposure of MG132. The implication of this finding is that the accumulated cleavage products are not generated by proteosome dependent degradation.
(ii). ICP0 cleavage products accumulated in larger amounts in the presence of MG132 in cells infected with the RING domain mutant (compare Fig. 3B lanes 5 and 6) Since ICP0 is sequestered in nuclei of cells infected with this mutant, we conclude that the initial cleavage of ICP0 takes place in the nucleus.
(iii). ICP0 cleavage products also accumulated in large amounts in cells infected with ⌬ICP4 mutant (Fig. 3B, lanes 7  and 8) . In this instance, as noted in the introduction, ICP0 is transported to the cytoplasm between 3 and 5 h after infection. In the cytoplasm it forms dense bodies that contain proteasomal components. One hypothesis that explains this observation is that proteasomal degradation of the initial cleavage products requires a post-translational modification that does not take place in the absence of ICP4. As a consequence, the products of ICP0 cleavage are transported into the cytoplasm and aggregate with proteasomal components. In the presence of MG132, ICP0 is retained in the nucleus, and hence the status of these polypeptides is similar to those of cells infected with the RING domain mutants.
Characterization of a Mutant Virus (R8515) Encoding a Chimeric
ICP0-EGFP Protein. To characterize more fully the initial cleavage products of ICP0, we constructed a mutant virus encoding a chimeric ICP0-EGFP protein as described in the Experimental Procedures. In this construct, the sequence encoding EGFP was inserted in frame with ICP0 as shown schematically in Fig. 4A . To characterize the chimeric protein, HEL cells grown on 4-well slides were exposed to 50 PFU of R8515 per cell for 2 h. The cells were then fixed, permeabilized, and reacted with anti-PML antibody and then stained with Alexa 594 conjugated secondary antibody and examined at wavelengths appropriate for EGFP (green) and PML (red) fluorescence with a Zeiss confocal microscope. Arrow No. 1 points to ND10 structures of a cell in which ICP0-EGFP and PML colocalize. In this instance, the amounts of ICP0-EGFP are very low. Arrow No. 2 points to a cell in which ICP0-EGFP filled the nucleus and accumulated also in the cytoplasm. In this cell as in other cells in a similar stage of viral replication, the ND10 structures and PML were no longer detectable.
Tentative Mapping of the Sites of Cleavage of ICP0. To map albeit tentatively the sites of initial cleavage of ICP0, HEL cells were harvested 7 h after mock infection or exposure to 5 PFU of wild-type, ⌬ICP0 (R8501), or ICP0-EGFP (R8515) mutant viruses per cell. Replicate samples from each cell lysate were loaded on the same denaturing gel for electrophoresis, with prestained marker bordering each group. After electrophoretic separation, the resolved proteins were transferred to PVDF membrane. The PVDF membrane containing each group of samples was cut according to the marker boundary and reacted with antibody to ICP0 domains encoded by exon 2 (Poly Ex 2 Ab), exon 3 (Mono Ex 3 Ab), or anti-GFP antibody (Mono EGFP Ab), respectively. The mapping of the probable cleavage site of ICP0 was based on the assumption that the larger cleavage products would react with more than one antibody whereas the smaller cleavage products could be expected to react with a single antibody. On the basis of the known location of epitopes of individual antibody (Fig. 5A) we calculated that there were at least two cleavage sites indicated by red arrows in Fig. 5A . If this were the case we could predict from the schematic representation shown in Fig. 5B that polypeptide 1 would react with one antibody only, polypeptide 2/3 with both antibody to exons 2 and 3, polypeptide 4 with antibody to exon 3 only, polypeptide 5/6 with antibodies to exon 3 and EGFP, and finally, polypeptide 7 with antibody to EGFP. The numbers to the left of the bands in Fig. 5C indicates the tentative assignment of polypeptide derivation. Band intensity of peptides 1, 2, and 3 suggest that the cleavage site around amino acid 400 accumulates more cleavage product than the cleavage site between residues 549 and 668. It should be noted that the electrophoretic mobility of ICP0 reflects the molecular weight of a protein greater than 775 residues. The electrophoretic mobility of the initial cleavage products may also fail their true molecular weights. While the estimated molecular weights are in rough agreement with the assigned position in ICP0, a definitive map must be constructed by other means.
Discussion
In this report we show the following: (i) ICP0 is rapidly degraded during its nuclear sojourn; its half life is approximately one h. Concomitant with the disappearance of the full-length protein, the infected cell accumulates polypeptides that form discrete bands in denaturing polyacrylamide gels. At least one such band with an apparent M r of 66,000 has a half life similar to that of full-length proteins. The accumulation of the truncated proteins was not blocked by proteasomal inhibitors MG132 or lactacystin. In contrast, the disappearance of the truncated forms of ICP0 was blocked by these proteasomal inhibitors. On the basis of the size and reactivity with different antibodies, we constructed a tentative cleavage map. The results are consistent with the hypothesis that ICP0 is initially cleaved by a protease(s) at two sites in the domain encoded by exon 3 and then to smaller products. Subsequently, the products of the initial cleavage are degraded by a proteasome-dependent process.
It is of historical interest that cleavage products of ICP0 were noted by Everett et al., but the authors concluded that they were artifacts of processing of the samples (13) . In subsequent studies on the role of ubiqiuitin-specific protease 7, the same laboratory showed for the most part narrow strips containing full-length ICP0 only (14, 15) . They concluded that the protease blocks degradation of ICP0 by proteasome dependent pathway, presumably the proteasome-dependent pathway reported here.
(ii). We should stress that the truncated polypeptides were visualized by both monoclonal and polyclonal antibodies directed to different domains of ICP0. The polypeptides accumulated in different cell lines and were virus strain independent.
Finally, they were also formed in cells transfected with a plasmid encoding ICP0 (see Fig. S3 ).
(iii). We infer that the initial cleavage of ICP0 takes place in the nucleus on the basis of evidence that in cells infected with a mutant unable to degrade PML or disperse ND10, these polypeptides accumulate in large amounts. Moreover, the initial degradation occurs during the early times after infection when ICP0 is known to be present in the nucleus and virtually ceases at 9 h after infection when ICP0 is in the cytoplasm. By the same token, the increased accumulation of the products of initial cleavage in cells that retain ICP0 in the nucleus in the absence of proteasomal inhibitors suggests that the proteasome dependent degradation takes place in the cytoplasm. Also relevant to this conclusion is the observation that truncated forms of ICP0 accumulate in cells at 9 h after infection with the ⌬ICP4 mutant virus. Confocal antibody studies, however, showed that long before that time point, ICP0 aggregates with proteasomal components in dense structures in the cytoplasm (9) . These observations suggest that the secondary degradation of ICP0 in ⌬ICP4 mutant-infected cells requires an event that does not take place in these cells. In place of degradation, the ICP0 products aggregate in dense bodies in the cytoplasm.
Lastly, the observation that ICP0 is cleaved in cells transfected with a plasmid encoding ICP0 suggests that the initial cleavage of ICP0 does not require other viral proteins.
Relevant to the results reported, one obvious question is whether any of the truncated forms of ICP0 could be the products of alternative splicing. There has been one report of a truncated ICP0, designated ICP0-R, which was derived by translation of an mRNA in which the intron between exons 2 and 3 was not spliced out (13) . In studies reported years ago, this laboratory suggested that ICP0 mRNA contains one splice donor and three splice acceptor sites (16) . However, numerous attempts to demonstrate the products of alternative splicing were not successful. The observation that the products of degradation of ICP0 encoded by the wild-type gene and by the cDNA genes are identical (compare Fig. 3A , lanes 2 and 6) is consistent with the hypothesis that the truncated forms of ICP0 arise as a consequence of proteolytic cleavage.
In Fig. 2 , we show that the relative amounts of the cleavage products decreases with time after infection. This is evident from comparisons of the accumulation of full-length ICP0 or of the 66-kDa product in the presence and absence of MG132 during the chase period. Given that the cleavage of ICP0 takes place in cells transfected with a plasmid encoding ICP0, that is, in the absence of all other viral proteins, it is tempting to speculate that the reduced rate of cleavage observed at late times after infection is due to either a post-translational modification of ICP0 or to a translocation into a compartment in which ICP0 is shielded from cleavage. It is noteworthy that ICP0 accumulating at 5 and 9 h after infection migrates more slowly-an indication of post-translational modification and that at 9 h after infection virtually all of ICP0 is translocated from the nucleus to the cytoplasm.
Lastly, the question arises as to whether the cleavage of ICP0 plays a specific role in the biology of HSV-1. One of the unresolved questions concerning the function of ICP0 is that immunoelectron microscopy with antibodies whose epitopes map upstream of residue 500 support the hypothesis that ICP0 localizes within the ND10 structure albeit not in direct apposition to PML (17) . In contrast, one of the targets of ICP0-the HDAC1-2/ CoREST/ REST/LSD1 repressor complex is most likely associated with the DNA that abuts but does not penetrate the ND10 structure (8) . Studies of the localization of CoREST by confocal microscopy are consistent with this conclusion. The obvious question is how does a protein contained entirely within ND10 acts on structures that abut but do not penetrate the ND10 bodies. Recent studies have shown that the function key to the 
